{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:21:51Z","timestamp":1756902111598,"version":"3.44.0"},"reference-count":34,"publisher":"The Pediatric Pharmacy Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"abstract":"\n OBJECTIVE<\/jats:title>\n To describe antibiotic susceptibilities for Staphylococcus aureus<\/jats:italic> and Pseudomonas aeruginosa<\/jats:italic> among pediatric institutions in 2018. To assess correlations between antibiotic utilization and susceptibilities.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n Institutional antibiograms from 2018 were compiled among 13 institutions via a survey. Resistant pathogens and antibiotic days of therapy\/1000 patient days (PD) were collected from 6 institutions over 5 years. Correlations were assessed as pooled data among all institutions and relative changes within individual institutions.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n All 8552 S aureus<\/jats:italic> isolates in 2018 were vancomycin susceptible and 40.1% were methicillin resistant (MRSA). Among MRSA, 96.3% and 78.8% were susceptible to trimethoprim\/sulfamethoxazole and clindamycin, respectively. Pooled yearly MRSA\/1000 PD decreased from 2014\u20132018 and correlated with pooled yearly decreases in vancomycin utilization (R<\/jats:italic> = 0.983, p = 0.003). Institutional relative decreases in vancomycin utilization from 2014\u20132018 did not correlate with institutional relative decreases in MRSA susceptibility (R<\/jats:italic> = \u22120.659, p = 0.16). Susceptibility to meropenem was 90.9% among 2315 P aeruginosa<\/jats:italic> isolates in 2018. Antipseudomonal beta-lactam susceptibility ranged from 89.4% to 92.3%. Pooled yearly meropenem-resistant P aeruginosa<\/jats:italic>\/1000 PD and meropenem utilization did not significantly decrease over time or correlate (both p > 0.6). Institutional relative change in meropenem utilization from 2013\u20132017 correlated with the institutional relative change in P aeruginosa<\/jats:italic> susceptibility to meropenem from 2014\u20132018 (Rs<\/jats:italic> = \u22120.89, p = 0.019).<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n Among included institutions, the burden of MRSA decreased over time. Institutional MRSA prevalence did not consistently correlate with institutional vancomycin utilization. Institutional changes in meropenem utilization correlated with P aeruginosa<\/jats:italic> susceptibility the following year. Pooled analyses did not illustrate this correlation, likely owing to variability in utilization between institutions.<\/jats:p>\n <\/jats:sec>","DOI":"10.5863\/1551-6776-27.4.330","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T19:17:05Z","timestamp":1652123825000},"page":"330-339","source":"Crossref","is-referenced-by-count":0,"title":["A Multicenter Analysis of Changes in Pediatric Antibiotic Susceptibilities Among Staphylococcus aureus and Pseudomonas aeruginosa Isolates: 2014\u20132018"],"prefix":"10.5863","volume":"27","author":[{"given":"Jeremy S.","family":"Stultz","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy and Translational Science (JSS, KRL), The University of Tennessee Health Science Center College of Pharmacy, Memphis, TN"},{"name":"Department of Pharmacy (JSS, KRL), Le Bonheur Children's Hospital, Memphis, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Benefield","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (EB), Primary Children's Hospital, Salt Lake City, UT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelley R.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Translational Science (JSS, KRL), The University of Tennessee Health Science Center College of Pharmacy, Memphis, TN"},{"name":"Department of Pharmacy (JSS, KRL), Le Bonheur Children's Hospital, Memphis, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferras","family":"Bashqoy","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (FB), Hassenfeld Children's Hospital at NYU Langone Health, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Pakyz","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Outcomes Science (ALP), Virginia Commonwealth University School of Pharmacy, Richmond, VA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"5","key":"i2331-348X-27-4-330-b1","series-title":"Infect Control Hosp Epidemiol","first-page":"571","article-title":"Considerable variability in antibiotic use among US children's hospitals in 2017\u20132018","volume":"41","year":"2020","unstructured":"Griffith\n HG,\n \n \n Dantuluri\n K,\n \n \n Thurm\n C,\n \n \n .\n\t\t\t\t\tConsiderable variability in antibiotic use among US children's hospitals in 2017\u20132018.\n\t\t\t\t\tInfect Control Hosp Epidemiol.\n\t\t\t\t\t2020;\n\t\t\t\t\t41(\n\t\t\t\t\t5):\n\t\t\t\t\t571\u2013\n\t\t\t\t\t578."},{"issue":"6","key":"i2331-348X-27-4-330-b2","series-title":"Pediatrics","first-page":"1067","article-title":"Variability in antibiotic use at children's hospitals","volume":"126","year":"2010","unstructured":"Gerber\n JS,\n \n \n Newland\n JG,\n \n \n Coffin\n SE,\n \n \n .\n\t\t\t\t\tVariability in antibiotic use at children's hospitals.\n\t\t\t\t\tPediatrics.\n\t\t\t\t\t2010;\n\t\t\t\t\t126(\n\t\t\t\t\t6):\n\t\t\t\t\t1067\u2013\n\t\t\t\t\t1073."},{"issue":"1","key":"i2331-348X-27-4-330-b3","series-title":"Infect Control Hosp Epidemiol","first-page":"1","article-title":"Pathogen distribution and antimicrobial resistance among pediatric healthcare-associated infections reported to the National Healthcare Safety Network, 2011\u20132014","volume":"39","year":"2018","unstructured":"Lake\n JG,\n \n \n Weiner\n LM,\n \n \n Milstone\n AM,\n \n \n .\n\t\t\t\t\tPathogen distribution and antimicrobial resistance among pediatric healthcare-associated infections reported to the National Healthcare Safety Network, 2011\u20132014.\n\t\t\t\t\tInfect Control Hosp Epidemiol.\n\t\t\t\t\t2018;\n\t\t\t\t\t39(\n\t\t\t\t\t1):\n\t\t\t\t\t1\u2013\n\t\t\t\t\t11."},{"issue":"5","key":"i2331-348X-27-4-330-b4","series-title":"Pediatr Infect Dis J","first-page":"507","article-title":"Bloodstream infections in hospitalized children: epidemiology and antimicrobial susceptibilities","volume":"35","year":"2016","unstructured":"Larru\n B,\n \n \n Gong\n W,\n \n \n Vendetti\n N,\n \n \n .\n\t\t\t\t\tBloodstream infections in hospitalized children: epidemiology and antimicrobial susceptibilities.\n\t\t\t\t\tPediatr Infect Dis J.\n\t\t\t\t\t2016;\n\t\t\t\t\t35(\n\t\t\t\t\t5):\n\t\t\t\t\t507\u2013\n\t\t\t\t\t510."},{"key":"i2331-348X-27-4-330-b5","series-title":"J Pediatr","first-page":"214","article-title":"Risk factors for complications in children with Staphylococcus aureus bacteremia","volume":"208","year":"2019","unstructured":"Hamdy\n RF,\n \n \n Dona\n D,\n \n \n Jacobs\n MB,\n \n \n Gerber\n JS.\n \n \n Risk factors for complications in children with Staphylococcus aureus bacteremia.\n\t\t\t\t\tJ Pediatr.\n\t\t\t\t\t2019;\n\t\t\t\t\t208:\n\t\t\t\t\t214\u2013\n\t\t\t\t\t220.e2."},{"issue":"5","key":"i2331-348X-27-4-330-b6","series-title":"Pediatr Infect Dis J","first-page":"429","article-title":"Reduced vancomycin susceptibility, MRSA and treatment failure in pediatric Staphylococcus aureus bloodstream infections","volume":"40","year":"2021","unstructured":"Canty\n E,\n \n \n Carnahan\n B,\n \n \n Curley\n T,\n \n \n .\n\t\t\t\t\tReduced vancomycin susceptibility, MRSA and treatment failure in pediatric Staphylococcus aureus bloodstream infections.\n\t\t\t\t\tPediatr Infect Dis J.\n\t\t\t\t\t2021;\n\t\t\t\t\t40(\n\t\t\t\t\t5):\n\t\t\t\t\t429\u2013\n\t\t\t\t\t433."},{"issue":"3","key":"i2331-348X-27-4-330-b7","series-title":"Clin Infect Dis","first-page":"e18","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","year":"2011","unstructured":"Liu\n C,\n \n \n Bayer\n A,\n \n \n Cosgrove\n SE,\n \n \n .\n\t\t\t\t\tClinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.\n\t\t\t\t\tClin Infect Dis.\n\t\t\t\t\t2011;\n\t\t\t\t\t52(\n\t\t\t\t\t3):\n\t\t\t\t\te18\u2013\n\t\t\t\t\te55."},{"issue":"12","key":"i2331-348X-27-4-330-b8","series-title":"Infect Control Hosp Epidemiol","first-page":"1487","article-title":"Epidemiology of Staphylococcus aureus infections in patients admitted to freestanding pediatric hospitals, 2009\u20132016","volume":"39","year":"2018","unstructured":"Spaulding\n AB,\n \n \n Thurm\n C,\n \n \n Courter\n JD,\n \n \n .\n\t\t\t\t\tEpidemiology of Staphylococcus aureus infections in patients admitted to freestanding pediatric hospitals, 2009\u20132016.\n\t\t\t\t\tInfect Control Hosp Epidemiol.\n\t\t\t\t\t2018;\n\t\t\t\t\t39(\n\t\t\t\t\t12):\n\t\t\t\t\t1487\u2013\n\t\t\t\t\t1490."},{"issue":"8","key":"i2331-348X-27-4-330-b9","series-title":"Infect Control Hosp Epidemiol","first-page":"993","article-title":"Development and application of an antibiotic spectrum index for benchmarking antibiotic selection patterns across hospitals","volume":"38","year":"2017","unstructured":"Gerber\n JS,\n \n \n Hersh\n AL,\n \n \n Kronman\n MP,\n \n \n .\n\t\t\t\t\tDevelopment and application of an antibiotic spectrum index for benchmarking antibiotic selection patterns across hospitals.\n\t\t\t\t\tInfect Control Hosp Epidemiol.\n\t\t\t\t\t2017;\n\t\t\t\t\t38(\n\t\t\t\t\t8):\n\t\t\t\t\t993\u2013\n\t\t\t\t\t997."},{"year":"2019","unstructured":"Centers for Disease Control and Prevention.\n \n Antibiotic resistance threats in the United States.\n\t\t\t\t\tAtlanta, GA:\n\t\t\t\t\tUS Department of Health and Human Services, Centers for Disease Control and Prevention;\n\t\t\t\t\t2019.\n\t\t\t\t\tAccessed February 16, 2021. www.cdc.gov\/DrugResistance\/Biggest-Threats.html","article-title":"Antibiotic resistance threats in the United States","key":"i2331-348X-27-4-330-b10"},{"key":"i2331-348X-27-4-330-b11","series-title":"Int J Infect Dis","first-page":"69","article-title":"Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality","volume":"64","year":"2017","unstructured":"Horikoshi\n Y,\n \n \n Suwa\n J,\n \n \n Higuchi\n H,\n \n \n .\n\t\t\t\t\tSustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality.\n\t\t\t\t\tInt J Infect Dis.\n\t\t\t\t\t2017;\n\t\t\t\t\t64:\n\t\t\t\t\t69\u2013\n\t\t\t\t\t73."},{"issue":"12","key":"i2331-348X-27-4-330-b12","series-title":"Am J Infect Control.","first-page":"1513","article-title":"Antimicrobial stewardship impact on Pseudomonas aeruginosa susceptibility to meropenem at a tertiary pediatric institution","volume":"47","year":"2019","unstructured":"Stultz\n JS,\n \n \n Arnold\n SR,\n \n \n Shelton\n CM,\n \n \n .\n\t\t\t\t\tAntimicrobial stewardship impact on Pseudomonas aeruginosa susceptibility to meropenem at a tertiary pediatric institution.\n\t\t\t\t\tAm J Infect Control.2019;\n\t\t\t\t\t47(\n\t\t\t\t\t12):\n\t\t\t\t\t1513\u2013\n\t\t\t\t\t1515."},{"issue":"6","key":"i2331-348X-27-4-330-b13","series-title":"J Pediatr Pharmacol Ther","first-page":"479","article-title":"Identification of factors associated with the desire to participate in a pediatric pharmacy practice-based research network","volume":"23","year":"2018","unstructured":"Stultz\n JS,\n \n \n Knoderer\n CA,\n \n \n Manasco\n KB,\n \n \n .\n\t\t\t\t\tIdentification of factors associated with the desire to participate in a pediatric pharmacy practice-based research network.\n\t\t\t\t\tJ Pediatr Pharmacol Ther.\n\t\t\t\t\t2018;\n\t\t\t\t\t23(\n\t\t\t\t\t6):\n\t\t\t\t\t479\u2013\n\t\t\t\t\t485."},{"issue":"2","key":"i2331-348X-27-4-330-b14","series-title":"J Biomed Inform","first-page":"377","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","year":"2009","unstructured":"Harris\n PA,\n \n \n Taylor\n R,\n \n \n Thielke\n R,\n \n \n .\n\t\t\t\t\tResearch electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support.\n\t\t\t\t\tJ Biomed Inform.\n\t\t\t\t\t2009;\n\t\t\t\t\t42(\n\t\t\t\t\t2):\n\t\t\t\t\t377\u2013\n\t\t\t\t\t381."},{"issue":"5","key":"i2331-348X-27-4-330-b15","series-title":"Antimicrob Agents Chemother","first-page":"1127","article-title":"Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study","volume":"41","year":"1997","unstructured":"Leibovici\n L,\n \n \n Paul\n M,\n \n \n Poznanski\n O,\n \n \n .\n\t\t\t\t\tMonotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.\n\t\t\t\t\tAntimicrob Agents Chemother.\n\t\t\t\t\t1997;\n\t\t\t\t\t41(\n\t\t\t\t\t5):\n\t\t\t\t\t1127\u2013\n\t\t\t\t\t1133."},{"issue":"4","key":"i2331-348X-27-4-330-b16","series-title":"Diagn Microbiol Infect Dis","first-page":"346","article-title":"Outcomes of empiric aminoglycoside monotherapy for Pseudomonas aeruginosa bacteremia","volume":"93","year":"2019","unstructured":"Phe\n K,\n \n \n Bowers\n DR,\n \n \n Babic\n JT,\n \n \n Tam\n VH.\n \n \n Outcomes of empiric aminoglycoside monotherapy for Pseudomonas aeruginosa bacteremia.\n\t\t\t\t\tDiagn Microbiol Infect Dis.\n\t\t\t\t\t2019;\n\t\t\t\t\t93(\n\t\t\t\t\t4):\n\t\t\t\t\t346\u2013\n\t\t\t\t\t348."},{"issue":"12","key":"i2331-348X-27-4-330-b17","series-title":"Nat Rev Microbiol","first-page":"979","article-title":"Epidemiological interpretation of antibiotic resistance studies\u2014what are we missing?","volume":"2","year":"2004","unstructured":"Schwaber\n MJ,\n \n \n De-Medina\n T,\n \n \n Carmeli\n Y.\n \n \n Epidemiological interpretation of antibiotic resistance studies\u2014what are we missing?\n \n Nat Rev Microbiol\n .\n\t\t\t\t\t2004;\n\t\t\t\t\t2(\n\t\t\t\t\t12):\n\t\t\t\t\t979\u2013\n\t\t\t\t\t983."},{"issue":"10","key":"i2331-348X-27-4-330-b18","series-title":"Clin Infect Dis","first-page":"e51","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","year":"2016","unstructured":"Barlam\n TF,\n \n \n Cosgrove\n SE,\n \n \n Abbo\n LM,\n \n \n .\n\t\t\t\t\tImplementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.\n\t\t\t\t\tClin Infect Dis.\n\t\t\t\t\t2016;\n\t\t\t\t\t62(\n\t\t\t\t\t10):\n\t\t\t\t\te51\u2013\n\t\t\t\t\te77."},{"issue":"5","key":"i2331-348X-27-4-330-b19","series-title":"J Pediatric Infect Dis Soc","first-page":"641","article-title":"Policy Statement: Antibiotic Stewardship in Pediatrics","volume":"10","year":"2021","unstructured":"Gerber\n JS,\n \n \n Jackson\n MA,\n \n \n Tamma\n PD,\n \n \n .\n\t\t\t\t\tPolicy Statement: Antibiotic Stewardship in Pediatrics.\n\t\t\t\t\tJ Pediatric Infect Dis Soc.\n\t\t\t\t\t2021;\n\t\t\t\t\t10(\n\t\t\t\t\t5):\n\t\t\t\t\t641\u2013\n\t\t\t\t\t649."},{"issue":"4","key":"i2331-348X-27-4-330-b20","series-title":"Pediatrics","first-page":"e20153099","article-title":"Changing susceptibility of Staphylococcus aureus in a US pediatric population","volume":"137","year":"2016","unstructured":"Sutter\n DE,\n \n \n Milburn\n E,\n \n \n Chukwuma\n U,\n \n \n .\n\t\t\t\t\tChanging susceptibility of Staphylococcus aureus in a US pediatric population.\n\t\t\t\t\tPediatrics.\n\t\t\t\t\t2016;\n\t\t\t\t\t137(\n\t\t\t\t\t4):\n\t\t\t\t\te20153099."},{"issue":"suppl 1","key":"i2331-348X-27-4-330-b21","series-title":"Open Forum Infect Dis","first-page":"S47","article-title":"Twenty-year trends in antimicrobial susceptibilities among Staphylococcus aureus from the SENTRY Antimicrobial Surveillance Program","volume":"6","year":"2019","unstructured":"Diekema\n DJ,\n \n \n Pfaller\n MA,\n \n \n Shortridge\n D,\n \n \n .\n\t\t\t\t\tTwenty-year trends in antimicrobial susceptibilities among Staphylococcus aureus from the SENTRY Antimicrobial Surveillance Program.\n\t\t\t\t\tOpen Forum Infect Dis.\n\t\t\t\t\t2019;\n\t\t\t\t\t6(\n\t\t\t\t\tsuppl 1):\n\t\t\t\t\tS47\u2013\n\t\t\t\t\tS53."},{"issue":"3","key":"i2331-348X-27-4-330-b22","series-title":"J Hosp Infect","first-page":"204","article-title":"Impact of alcohol hand-rub use on meticillin-resistant Staphylococcus aureus: an analysis of the literature","volume":"74","year":"2010","unstructured":"Sroka\n S,\n \n \n Gastmeier\n P,\n \n \n Meyer\n E.\n \n \n Impact of alcohol hand-rub use on meticillin-resistant Staphylococcus aureus: an analysis of the literature.\n\t\t\t\t\tJ Hosp Infect.\n\t\t\t\t\t2010;\n\t\t\t\t\t74(\n\t\t\t\t\t3):\n\t\t\t\t\t204\u2013\n\t\t\t\t\t211."},{"issue":"7","key":"i2331-348X-27-4-330-b23","series-title":"N Engl J Med","first-page":"638","article-title":"Decolonization to reduce postdischarge infection risk among MRSA carriers","volume":"380","year":"2019","unstructured":"Huang\n SS,\n \n \n Singh\n R,\n \n \n McKinnell\n JA,\n \n \n .\n\t\t\t\t\tDecolonization to reduce postdischarge infection risk among MRSA carriers.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2019;\n\t\t\t\t\t380(\n\t\t\t\t\t7):\n\t\t\t\t\t638\u2013\n\t\t\t\t\t650."},{"issue":"7","key":"i2331-348X-27-4-330-b24","series-title":"Infect Control Hosp Epidemiol","first-page":"772","article-title":"Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update","volume":"35","year":"2014","unstructured":"Calfee\n DP,\n \n \n Salgado\n CD,\n \n \n Milstone\n AM,\n \n \n .\n\t\t\t\t\tStrategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update.\n\t\t\t\t\tInfect Control Hosp Epidemiol.\n\t\t\t\t\t2014;\n\t\t\t\t\t35(\n\t\t\t\t\t7):\n\t\t\t\t\t772\u2013\n\t\t\t\t\t796."},{"issue":"1","key":"i2331-348X-27-4-330-b25","series-title":"J Antimicrob Chemother","first-page":"26","article-title":"Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation: a systematic review and meta-analysis","volume":"61","year":"2008","unstructured":"Tacconelli\n E,\n \n \n De Angelis\n G,\n \n \n Cataldo\n MA,\n \n \n .\n\t\t\t\t\tDoes antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation: a systematic review and meta-analysis.\n\t\t\t\t\tJ Antimicrob Chemother.\n\t\t\t\t\t2008;\n\t\t\t\t\t61(\n\t\t\t\t\t1):\n\t\t\t\t\t26\u2013\n\t\t\t\t\t38."},{"issue":"10","key":"i2331-348X-27-4-330-b26","series-title":"Antimicrob Agents Chemother","first-page":"e00609","article-title":"Impact of antibiotic treatment on the burden of nasal Staphylococcus aureus among hospitalized patients","volume":"62","year":"2018","unstructured":"Kanwar\n A,\n \n \n Cadnum\n JL,\n \n \n Jencson\n AL,\n \n \n Donskey\n CJ.\n \n \n Impact of antibiotic treatment on the burden of nasal Staphylococcus aureus among hospitalized patients.\n\t\t\t\t\tAntimicrob Agents Chemother.\n\t\t\t\t\t2018;\n\t\t\t\t\t62(\n\t\t\t\t\t10):\n\t\t\t\t\te00609\u2013\n\t\t\t\t\te00618."},{"issue":"11","key":"i2331-348X-27-4-330-b27","series-title":"Am J Health Syst Pharm","first-page":"835","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","year":"2020","unstructured":"Rybak\n MJ,\n \n \n Le\n J,\n \n \n Lodise\n TP,\n \n \n .\n\t\t\t\t\tTherapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.\n\t\t\t\t\tAm J Health Syst Pharm.\n\t\t\t\t\t2020;\n\t\t\t\t\t77(\n\t\t\t\t\t11):\n\t\t\t\t\t835\u2013\n\t\t\t\t\t864."},{"issue":"8","key":"i2331-348X-27-4-330-b28","series-title":"J Pediatric Infect Dis Soc","first-page":"801","article-title":"Clinical Practice Guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics","volume":"10","year":"2021","unstructured":"Woods\n CR,\n \n \n Bradley\n JS,\n \n \n Chatterjee\n A,\n \n \n .\n\t\t\t\t\tClinical Practice Guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics.\n\t\t\t\t\tJ Pediatric Infect Dis Soc.\n\t\t\t\t\t2021;\n\t\t\t\t\t10(\n\t\t\t\t\t8):\n\t\t\t\t\t801\u2013\n\t\t\t\t\t844."},{"issue":"suppl 4","key":"i2331-348X-27-4-330-b29","series-title":"J Antimicrob Chemother","first-page":"iv55","article-title":"Characterization of MRSA in Canada from 2007 to 2016","volume":"74","year":"2019","unstructured":"Nichol\n KA,\n \n \n Adam\n HJ,\n \n \n Golding\n GR,\n \n \n .\n\t\t\t\t\tCharacterization of MRSA in Canada from 2007 to 2016.\n\t\t\t\t\tJ Antimicrob Chemother.\n\t\t\t\t\t2019;\n\t\t\t\t\t74(\n\t\t\t\t\tsuppl 4):\n\t\t\t\t\tiv55\u2013\n\t\t\t\t\tiv63."},{"issue":"12","key":"i2331-348X-27-4-330-b30","series-title":"Infect Control Hosp Epidemiol","first-page":"1244","article-title":"Pediatric antimicrobial susceptibility trends across the United States","volume":"34","year":"2013","unstructured":"Tamma\n PD,\n \n \n Robinson\n GL,\n \n \n Gerber\n JS,\n \n \n .\n\t\t\t\t\tPediatric antimicrobial susceptibility trends across the United States.\n\t\t\t\t\tInfect Control Hosp Epidemiol.\n\t\t\t\t\t2013;\n\t\t\t\t\t34(\n\t\t\t\t\t12):\n\t\t\t\t\t1244\u2013\n\t\t\t\t\t1251."},{"issue":"suppl 1","key":"i2331-348X-27-4-330-b31","series-title":"Open Forum Infect Dis","first-page":"S63","article-title":"Geographic and temporal patterns of antimicrobial resistance in Pseudomonas aeruginosa over 20 years from the SENTRY Antimicrobial Surveillance Program, 1997\u20132016","volume":"6","year":"2019","unstructured":"Shortridge\n D,\n \n \n Gales\n AC,\n \n \n Streit\n JM,\n \n \n .\n\t\t\t\t\tGeographic and temporal patterns of antimicrobial resistance in Pseudomonas aeruginosa over 20 years from the SENTRY Antimicrobial Surveillance Program, 1997\u20132016.\n\t\t\t\t\tOpen Forum Infect Dis.\n\t\t\t\t\t2019;\n\t\t\t\t\t6(\n\t\t\t\t\tsuppl 1):\n\t\t\t\t\tS63\u2013\n\t\t\t\t\tS68."},{"issue":"2","key":"i2331-348X-27-4-330-b32","series-title":"Clin Infect Dis","first-page":"133","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","year":"2010","unstructured":"Solomkin\n JS,\n \n \n Mazuski\n JE,\n \n \n Bradley\n JS,\n \n \n .\n\t\t\t\t\tDiagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.\n\t\t\t\t\tClin Infect Dis.\n\t\t\t\t\t2010;\n\t\t\t\t\t50(\n\t\t\t\t\t2):\n\t\t\t\t\t133\u2013\n\t\t\t\t\t164."},{"issue":"2","key":"i2331-348X-27-4-330-b33","series-title":"Pediatr Crit Care Med","first-page":"e52","article-title":"Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children","volume":"21","year":"2020","unstructured":"Weiss\n SL,\n \n \n Peters\n MJ,\n \n \n Alhazzani\n W,\n \n \n .\n\t\t\t\t\tSurviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children.\n\t\t\t\t\tPediatr Crit Care Med.\n\t\t\t\t\t2020;\n\t\t\t\t\t21(\n\t\t\t\t\t2):\n\t\t\t\t\te52\u2013\n\t\t\t\t\te106."},{"issue":"8","key":"i2331-348X-27-4-330-b34","series-title":"J Infect Chemother","first-page":"532","article-title":"Impact of computerized pre-authorization of broad spectrum antibiotics in Pseudomonas aeruginosa at a children's hospital in Japan","volume":"22","year":"2016","unstructured":"Horikoshi\n Y,\n \n \n Higuchi\n H,\n \n \n Suwa\n J,\n \n \n .\n\t\t\t\t\tImpact of computerized pre-authorization of broad spectrum antibiotics in Pseudomonas aeruginosa at a children's hospital in Japan.\n\t\t\t\t\tJ Infect Chemother.\n\t\t\t\t\t2016;\n\t\t\t\t\t22(\n\t\t\t\t\t8):\n\t\t\t\t\t532\u2013\n\t\t\t\t\t535."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/27\/4\/article-p330.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/27\/4\/330\/3060099\/i2331-348x-27-4-330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/27\/4\/article-p330.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/27\/4\/article-p330.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:37:36Z","timestamp":1747355856000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/27\/4\/article-p330.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":34,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-27.4.330","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"type":"electronic","value":"2331-348X"},{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2022]]}}}